Morgan Stanley Maintains Overweight on Vistra, Raises Price Target to $227

Benzinga Newsdesk www.benzinga.com Positive 80.7%

Neg 0% Neu 0% Pos 80.7%

Morgan Stanley analyst Stephen Byrd maintains Vistra (NYSE:VST) with a Overweight and raises the price target from $212 to $227.